Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Tangible Net Worth Ratio
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Tangible Net Worth Ratio of 82.2% as of March 2026. This metric is calculated by deducting intangible assets (CN¥193.95 Million) from net assets (CN¥1.09 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 688488 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jiangsu Aidea Pharmaceutical Co Ltd Tangible Net Worth Ratio (2016–2025)
This chart shows how Jiangsu Aidea Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 82.2%, reflecting net assets of CN¥1.09 Billion with intangible assets of CN¥193.95 Million CNY. For live market cap and overall valuation, see Jiangsu Aidea Pharmaceutical Co Ltd (688488) market capitalisation.
Annual Tangible Net Worth Ratio for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Jiangsu Aidea Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.3% | CN¥1.07 Billion | CN¥190.18 Million | CN¥1.91 Billion | ▼ -0.8 pp |
| 2024 | 83.1% | CN¥1.07 Billion | CN¥180.41 Million | CN¥1.87 Billion | ▲ +1.2 pp |
| 2023 | 81.9% | CN¥1.13 Billion | CN¥203.72 Million | CN¥1.75 Billion | ▼ -3.0 pp |
| 2022 | 84.9% | CN¥1.20 Billion | CN¥181.07 Million | CN¥1.66 Billion | ▼ -2.5 pp |
| 2021 | 87.4% | CN¥1.31 Billion | CN¥165.14 Million | CN¥1.43 Billion | ▼ -1.9 pp |
| 2020 | 89.2% | CN¥1.36 Billion | CN¥146.21 Million | CN¥1.45 Billion | ▲ +12.6 pp |
| 2019 | 76.6% | CN¥556.24 Million | CN¥130.02 Million | CN¥780.98 Million | ▼ -3.4 pp |
| 2018 | 80.0% | CN¥522.71 Million | CN¥104.49 Million | CN¥708.95 Million | ▼ -4.7 pp |
| 2017 | 84.7% | CN¥514.09 Million | CN¥78.45 Million | CN¥659.24 Million | ▲ +9.7 pp |
| 2016 | 75.0% | CN¥300.40 Million | CN¥74.97 Million | CN¥443.55 Million | — |